Ownership history in Redmile Group, LLC · 12 quarters on record
This page tracks every 13F SEC filing in which Redmile Group, LLC reported a position in PRIME MEDICINE INC (PRME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 87,118 | -1,987,232 | -95.8% | 0.05% | $483K | $5.54 |
| 2025 Q2 | UNCHANGED | 2,074,350 | — | 0% | 0.55% | $5.1M | $2.47 |
| 2025 Q1 | UNCHANGED | 2,074,350 | — | 0% | 0.39% | $4.1M | $1.99 |
| 2024 Q4 | UNCHANGED | 2,074,350 | — | 0% | 0.42% | $6.1M | $2.92 |
| 2024 Q3 | UNCHANGED | 2,074,350 | — | 0% | 0.47% | $8.0M | $3.87 |
| 2024 Q2 | UNCHANGED | 2,074,350 | — | 0% | 0.64% | $10.7M | $5.14 |
| 2024 Q1 | ADDED | 2,074,350 | +750,000 | +56.6% | 0.53% | $14.5M | $7.00 |
| 2023 Q4 | UNCHANGED | 1,324,350 | — | 0% | 0.42% | $11.7M | $8.86 |
| 2023 Q3 | UNCHANGED | 1,324,350 | — | 0% | 0.60% | $12.6M | $9.54 |
| 2023 Q2 | REDUCED | 1,324,350 | -668,493 | -33.5% | 0.74% | $19.4M | $14.65 |
As of 2025 Q4 — sorted by position size